I am thinking it's announcement of a Big Pharma partner for a global Phase III study of IMM-124E in NASH. Also looking for more U.S. defense department results on their testing of Travelan, and possibly an order.
Things are looking great, guys. Big Pharma JV for IMM-124E global Phase III in NASH will send the stock through the roof. It will easily see $150-200M USD market cap at that point. That's about 3X-6X the current price. Get 'em while they're still cheap![]()
Add to My Watchlist
What is My Watchlist?
